142
Views
9
CrossRef citations to date
0
Altmetric
Original Research

Women’s preferences, willingness-to-pay, and predicted uptake for single-nucleotide polymorphism gene testing to guide personalized breast cancer screening strategies: a discrete choice experiment

, , , , , , & show all
Pages 1837-1852 | Published online: 18 Sep 2018

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Omer Ben-Aharon, Georgi Iskrov, Iftach Sagy & Dan Greenberg. (2023) Willingness to pay for cancer prevention, screening, diagnosis, and treatment: a systematic review. Expert Review of Pharmacoeconomics & Outcomes Research 23:3, pages 281-295.
Read now

Articles from other publishers (8)

Zahra Meshkani, Najmeh Moradi, Ali Aboutorabi, Abdosaleh Jafari & Roshanak Shams. (2023) Subjective valuation of Iranian women for screening for gene-related diseases: a case of breast cancer. BMC Public Health 23:1.
Crossref
Prisca O. Adejumo, Toyin I.G. Aniagwu, Olutosin A. Awolude, Babatunde Adedokun, Makayla Kochheiser, Anthonia Sowunmi, Abiodun Popoola, Oladosu Ojengbede, Dezheng Huo & Olufunmilayo I. Olopade. (2023) Cancer Genetic Services in a Low- to Middle-Income Country: Cross-Sectional Survey Assessing Willingness to Undergo and Pay for Germline Genetic Testing. JCO Global Oncology:9.
Crossref
Brent Venning, Sibel Saya, Richard De Abreu Lourenco, Deborah J. Street & Jon D. Emery. (2022) Preferences for a polygenic test to estimate cancer risk in a general Australian population. Genetics in Medicine 24:10, pages 2144-2154.
Crossref
Jenny Liu, Peh Joo Ho, Tricia Hui Ling Tan, Yen Shing Yeoh, Ying Jia Chew, Nur Khaliesah Mohamed Riza, Alexis Jiaying Khng, Su-Ann Goh, Yi Wang, Han Boon Oh, Chi Hui Chin, Sing Cheer Kwek, Zhi Peng Zhang, Desmond Luan Seng Ong, Swee Tian Quek, Chuan Chien Tan, Hwee Lin Wee, Jingmei Li, Philip Tsau Choong Iau & Mikael Hartman. (2022) BREAst screening Tailored for HEr (BREATHE)—A study protocol on personalised risk-based breast cancer screening programme. PLOS ONE 17:3, pages e0265965.
Crossref
Semra Ozdemir, Jia Jia Lee, Isha Chaudhry & Remee Rose Quintana Ocampo. (2021) A Systematic Review of Discrete Choice Experiments and Conjoint Analysis on Genetic Testing. The Patient - Patient-Centered Outcomes Research 15:1, pages 39-54.
Crossref
Jerry Zeng Yang Wong, Jia Hui Chai, Yen Shing Yeoh, Nur Khaliesah Mohamed Riza, Jenny Liu, Yik-Ying Teo, Hwee Lin Wee & Mikael Hartman. (2021) Cost effectiveness analysis of a polygenic risk tailored breast cancer screening programme in Singapore. BMC Health Services Research 21:1.
Crossref
Azimatun Noor Aizuddin, Abdul Rahman Ramdzan, Sharifah Azween Syed Omar, Zuria Mahmud, Zarina A. Latiff, Salleh Amat, Keng Wee Teik, Ch’ng Gaik Siew, Haniza Rais & Syed Mohamed Aljunid. (2021) Genetic Testing for Cancer Risk: Is the Community Willing to Pay for It?. International Journal of Environmental Research and Public Health 18:16, pages 8752.
Crossref
Sibel Saya, Jennifer G. McIntosh, Ingrid M. Winship, Mark Clendenning, Shakira Milton, Jasmeen Oberoi, James G. Dowty, Daniel D. Buchanan, Mark A. Jenkins & Jon D. Emery. (2020) A Genomic Test for Colorectal Cancer Risk: Is This Acceptable and Feasible in Primary Care?. Public Health Genomics 23:3-4, pages 110-121.
Crossref